Home Funding Iron Path Capital Closes Fund I, Exceeds Target at $273 Mn

[Funding News] Iron Path Capital Closes Fund I, Exceeds Target at $273 Mn

0
Iron Path Capital, an operationally focused private equity firm investing in the specialty industrials and healthcare sectors, announced the final closing of Iron Path Capital Fund I (“Fund I”), exceeding the $250 million target with total commitments of $273 million.
Iron Path Capital, an operationally focused private equity firm investing in the specialty industrials and healthcare sectors, announced the final closing of Iron Path Capital Fund I (“Fund I”), exceeding the $250 million target with total commitments of $273 million.
Iron Path Capital, an operationally focused private equity firm investing in the specialty industrials and healthcare sectors, announced the final closing of Iron Path Capital Fund I (“Fund I”), exceeding the $250 million target with total commitments of $273 million.

Iron Path Capital, an operationally focused private equity firm investing in the specialty industrials and healthcare sectors, announced the final closing of Iron Path Capital Fund I (“Fund I”), exceeding the $250 million target with total commitments of $273 million.

Read also – Metrika and Zodia Custody Partner on Digital Asset Risk Management

The Fund I limited partners consist of a diverse group of global investors including leading endowments, fund of funds, institutional investors and family offices.M2O Private Fund Advisors acted as the exclusive placement agent. Foley & Lardner LLP served as fund counsel.

Read also – [Funding News] Rejuvenate Bio Raises $4M Funding from the California Institute for Regenerative Medicine

“We are extremely grateful for the investors that have decided to partner with us in our inaugural institutional fund,” said Iron Path Managing Partner and Co-founder Rob Reistetter. “This marks an important achievement for the firm and is a reflection of our differentiated capabilities and the strong team that we have built over our first three years.”

Iron Path Capital targets control investments in lower-middle market specialty industrial and healthcare companies, in partnership with founders and managers, to build and grow great businesses. Iron Path focuses on sectors where the firm has deep expertise and where they can create transformational outcomes with the operational resources of the Full Immersion Operations team (“FIOps™”).

“Our approach includes developing an investment thesis and partnering with founders and managers to scale businesses organically and with strategic acquisitions,” said Scott Mraz, fellow co-founder and Managing Partner. “We have curated a team of limited partners, strategic advisors and Iron Path professionals who share our unique vision and our steadfast values.”

About Iron Path Capital

Iron Path Capital is an operationally focused private equity firm focused on lower-middle-market investments across the healthcare and specialty industrial sectors. With offices in Nashville, TN and Charlottesville, VA, Iron Path Capital supports its partners with capital, operating expertise, business development, and industry relationships to achieve significant scale. Iron Path Capital selects companies with stable cash flows, superior management teams, strong performance trajectories, and multiple vectors for growth, both organic and through consolidation.

Exit mobile version